Siemens Fonds Invest’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Siemens Fonds Invest's BMY Position: Q1 2026 in Review
Siemens Fonds Invest reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q1 2026, selling an estimated $77.2K and leaving 73,334 shares worth $4.45M. The position accounts for 0.25% of the portfolio, ranked #92.
Siemens Fonds Invest first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $10.6M in Q4 2020. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Siemens Fonds Invest held 73,334 shares of Bristol-Myers Squibb worth $4.45M as of Q1 2026.
- Siemens Fonds Invest sold 1,324 Bristol-Myers Squibb shares in Q1 2026, an estimated $77.2K.
- Bristol-Myers Squibb made up 0.25% of Siemens Fonds Invest's portfolio in Q1 2026, its #92 holding.
- Siemens Fonds Invest first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
- Siemens Fonds Invest's Bristol-Myers Squibb position peaked at $10.6M in Q4 2020.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Siemens Fonds Invest's 13F filing for Q1 2026, filed 15 May 2026.